Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
enVVeno Medical Corporation (NVNO) had Cash Flow from Financial Activities of $13.64M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-21.82M |
|
-- |
|
-- |
|
$23.83M |
|
$-23.83M |
|
$2.01M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-23.83M |
|
$-23.30M |
|
17.14M |
|
17.14M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$43.73M |
|
$0.18M |
|
$1.22M |
|
$44.95M |
|
$2.10M |
|
-- |
|
$0.70M |
|
$2.79M |
|
$42.16M |
|
$42.16M |
|
$42.16M |
|
17.54M |
|
| Cash Flow Statement Financials | |
$-16.84M |
|
$1.33M |
|
|
Cash Flow from Financial Activities |
$13.64M |
$3.62M |
|
$1.75M |
|
$-1.87M |
|
$4.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-51.75% |
|
-51.75% |
|
-48.54% |
|
-51.75% |
|
$2.40 |
|
$-0.98 |
|
$-0.98 |
|